Delay in Diagnostic Workup and Treatment of Esophageal Cancer

被引:62
|
作者
Grotenhuis, Brechtje A. [1 ]
van Hagen, Pieter [1 ]
Wijnhoven, Bas P. L. [1 ]
Spaander, Manon C. W. [2 ]
Tilanus, Hugo W. [1 ]
van Lanschot, Jan J. B. [1 ]
机构
[1] Erasmus Univ, Dept Surg, Erasmus Med Ctr, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus Univ, Dept Gastroenterol, Erasmus Med Ctr, NL-3000 CA Rotterdam, Netherlands
关键词
Esophageal cancer; Diagnostic workup; Delay; Waiting list; Survival; LIMITED TRANSHIATAL RESECTION; PROGNOSTIC-FACTORS; THERAPEUTIC DELAY; SURVIVAL; CARCINOMA; ADENOCARCINOMA; SURGERY; IMPACT; STAGE; TIME;
D O I
10.1007/s11605-009-1109-y
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Esophageal cancer should preferably be detected and treated at an early stage, but this may be prohibited by late onset of symptoms and delays in referral, diagnostic workup, and treatment. The aim of this study was to investigate the impact of these delays on outcome in patients with esophageal cancer. For 491 patients undergoing esophagectomy for cancer between 1991 and 2007, patients' short- and long-term outcome were analyzed according to different time intervals between onset of symptoms, diagnosis, and surgical treatment. Length of prehospital delay (from onset of symptoms until endoscopic diagnosis) did not affect patient's short- or long-term outcome. A shorter hospital delay between establishing the diagnosis of esophageal cancer on endoscopy and surgery was associated with lower overall morbidity and in-hospital mortality. Patients of ASA classes I and II experienced a shorter hospital delay than patients of ASA classes III and IV. Length of hospital delay between endoscopic diagnosis and surgery did not affect pathological tumor-node-metastasis stage or R0-resection rate. Longer hospital delay did not result in worse survival: Overall survival after esophagectomy for cancer was not significantly different between patients with hospital delay < 5, 5-8, or > 8 weeks (24.7%, 21.7%, and 32.3%, respectively; p = 0.12). A longer hospital delay (between endoscopic diagnosis and surgery) resulted in worse patient's short-term outcome (higher overall morbidity and mortality rates) but not in a worse long-term outcome (overall survival). This may be explained by a more time-consuming diagnostic workup in patients with a poorer physical status and not by tumor progression.
引用
收藏
页码:476 / 483
页数:8
相关论文
共 50 条
  • [1] Delay in Diagnostic Workup and Treatment of Esophageal Cancer
    Brechtje A. Grotenhuis
    Pieter van Hagen
    Bas P. L. Wijnhoven
    Manon C. W. Spaander
    Hugo W. Tilanus
    Jan J. B. van Lanschot
    Journal of Gastrointestinal Surgery, 2010, 14 : 476 - 483
  • [2] The effect of socioeconomic status on health-care delay and treatment of esophageal cancer
    Wang, Nana
    Cao, Fangli
    Liu, Fang
    Jia, Yibin
    Wang, Jianbo
    Bao, Cihang
    Wang, Xintong
    Song, Qingxu
    Tan, Bingxu
    Cheng, Yufeng
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [3] Treatment and outcome of young patients with esophageal cancer in the Netherlands
    Van Nistelrooij, Anna M. J.
    Van Steenbergen, Liza N.
    Spaander, Manon C. W.
    Tilanus, Hugo W.
    Van Lanschot, J. Jan B.
    Lemmens, Valery E. P. P.
    Wijnhoven, Bas P. L.
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (06) : 561 - 566
  • [4] Actual diagnostic and therapeutic aspects in esophageal cancer
    Porschen, R.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (36) : 1778 - 1783
  • [5] Multilevel Approaches to Reducing Diagnostic and Treatment Delay in Colorectal Cancer
    Gorin, Sherri Sheinfeld
    ANNALS OF FAMILY MEDICINE, 2019, 17 (05) : 386 - 389
  • [6] Impact of optimizing diagnostic workup and reducing the time to treatment in head and neck cancer
    Schutte, Henrieke W.
    van den Broek, Guido B.
    Steens, Stefan C. A.
    Hermens, Rosella P. M. G.
    Honings, Jimmie
    Marres, Henri A. M.
    Merkx, Matthias A. W.
    Weijs, Willem L. J.
    Arens, Anne I. J.
    van Engen-van Grunsven, Adriana C. H.
    van Herpen, Carla M. L.
    Kaanders, Johannes H. A. M.
    van den Hoogen, Frank J. A.
    Takes, Robert P.
    CANCER, 2020, 126 (17) : 3982 - 3990
  • [7] Effect of histologic subtype on treatment and outcomes for esophageal cancer in the United States
    Merkow, Ryan P.
    Bilimoria, Karl Y.
    McCarter, Martin D.
    Chow, Warren B.
    Gordon, Howard S.
    Stewart, Andrew K.
    Ko, Clifford Y.
    Bentrem, David J.
    CANCER, 2012, 118 (13) : 3268 - 3276
  • [8] Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities
    Napier, Kyle J.
    Scheerer, Mary
    Misra, Subhasis
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2014, 6 (05) : 112 - 120
  • [9] Esophageal cancer: A Review of epidemiology, pathogenesis, staging workup and treatment modalities
    Kyle J Napier
    Mary Scheerer
    Subhasis Misra
    World Journal of Gastrointestinal Oncology, 2014, 6 (05) : 112 - 120
  • [10] What is the role of neoadjuvant chemotherapy, radiation, and adjuvant treatment in resectable esophageal cancer?
    Altorki, Nasser
    Harrison, Sebron
    ANNALS OF CARDIOTHORACIC SURGERY, 2017, 6 (02) : 167 - 174